AvePoint (AVPT) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AVPT SEC filings page.
AvePoint, Inc. (AVPT) reported $466.2M in revenue over the twelve months to Jun 30, 2026, up 25.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
AvePoint's growth has crossed into profitability, with cash generation far exceeding reported earnings while reinvestment remains modest.
In FY2025, operating cash flow of$85M was245.0% of net income, so reported profit understated cash production. Free cash flow reached$82M against only$4M of capital expenditures, revealing a low-reinvestment cash model rather than a business consuming cash to produce accounting earnings.
The profit inflection looks like operating-cost absorption, not a wholesale change in gross economics: operating margin improved
The balance sheet also became less liability-heavy: assets expanded
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of AvePoint, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
AvePoint, Inc. has an operating margin of 7.9%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 37/100, indicating healthy but not exceptional operating efficiency. This is up from 2.2% the prior year.
AvePoint, Inc.'s revenue surged 26.9% year-over-year to $419.5M, reflecting rapid business expansion. This strong growth earns a score of 85/100.
With a current ratio of 2.28, AvePoint, Inc. holds $2.28 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 66/100.
AvePoint, Inc. converts 19.4% of revenue into free cash flow ($81.6M). This strong cash generation earns a score of 86/100.
AvePoint, Inc.'s ROE of 7.3% shows moderate profitability relative to equity, earning a score of 34/100. This is up from -10.8% the prior year.
AvePoint, Inc. scores 7.19, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $3.6B against total liabilities of $310.5M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
AvePoint, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, AvePoint, Inc. generates $2.45 in operating cash flow ($85.3M OCF vs $34.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
AvePoint, Inc. generated $124.5M in revenue in Q2 2026. This represents an increase of 22.0% from the same quarter a year earlier. Against the prior quarter it is up 6.2%.
AvePoint, Inc. reported $27.6M in net income in Q2 2026. This represents an increase of 921.9% from the same quarter a year earlier. Against the prior quarter it is up 80.8%.
AvePoint, Inc. earned $0.12 per diluted share (EPS) in Q2 2026. This represents an increase of 1100.0% from the same quarter a year earlier. Against the prior quarter it is up 71.4%.
Not reported for Q2 2026.
Cash & Balance Sheet
AvePoint, Inc. generated $14.7M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 23.7% from the same quarter a year earlier. Against the prior quarter it is down 35.9%.
AvePoint, Inc. held $417.3M in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Margins & Returns
AvePoint, Inc.'s gross margin was 73.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
AvePoint, Inc.'s operating margin was 8.2% in Q2 2026, reflecting core business profitability. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.6 percentage points.
AvePoint, Inc.'s net profit margin was 22.1% in Q2 2026, showing the share of revenue converted to profit. This is up 19.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.1 percentage points.
AvePoint, Inc.'s quarterly ROE was 6.3% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 5.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.8 percentage points.
Capital Allocation
AvePoint, Inc. invested $16.6M in research and development in Q2 2026. This represents an increase of 27.8% from the same quarter a year earlier. Against the prior quarter it is up 20.4%.
AvePoint, Inc. spent $50.5M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 616.6% from the same quarter a year earlier. Against the prior quarter it is down 15.5%.
AvePoint, Inc. invested $1.2M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 25.1% from the same quarter a year earlier. Against the prior quarter it is down 5.5%.
AVPT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $124.5M+22.0% | $117.2M+26.0% | $114.7M+28.6% | $109.7M+23.6% | $102.0M+30.9% | $93.1M+24.9% | $89.2M+19.5% | $88.8M+22.1% |
| Cost of Revenue | $33.5M+26.5% | $31.9M+33.4% | $30.3M+38.1% | $28.1M+32.6% | $26.5M+39.8% | $23.9M+16.9% | $21.9M+11.7% | $21.2M+5.3% |
| Gross Profit | $91.0M+20.5% | $85.4M+23.4% | $84.4M+25.5% | $81.6M+20.7% | $75.5M+28.0% | $69.2M+27.9% | $67.3M+22.3% | $67.6M+28.5% |
| R&D Expenses | $16.6M+27.8% | $13.8M+8.4% | $13.0M+1.0% | $13.9M+8.6% | $13.0M+3.7% | $12.7M+21.0% | $12.9M+36.8% | $12.8M+48.5% |
| SG&A Expenses | $64.2M+15.7% | $58.9M+10.7% | $56.9M+14.8% | $59.5M+26.4% | $55.5M+14.0% | $53.2M+13.6% | $49.5M+10.8% | $47.1M+6.4% |
| Operating Income | $10.2M+44.1% | $12.7M+287.2% | $14.5M+199.3% | $8.1M+6.2% | $7.1Mn/m | $3.3Mn/m | $4.9M+452.7% | $7.7Mn/m |
| Income Tax | -$15.6M-492.8% | $1.3M-1.5% | $323Kn/m | -$210K-214.8% | $4.0M+3.4% | $1.3M-39.4% | -$1.4Mn/m | $183K-93.6% |
| Net Income | $27.6M+921.9% | $15.3M+343.3% | $15.6Mn/m | $13.0M+396.8% | $2.7Mn/m | $3.4Mn/m | -$17.2M-502.6% | $2.6Mn/m |
| EPS (Basic) | $0.13+1200.0% | $0.07+250.0% | $0.08n/m | $0.06+500.0% | $0.01n/m | $0.02n/m | -$0.09-550.0% | $0.01n/m |
| EPS (Diluted) | $0.12+1100.0% | $0.07+250.0% | $0.07n/m | $0.06+500.0% | $0.01n/m | $0.02n/m | -$0.09 | $0.01n/m |
| Diluted Shares (Avg) | 221M-3.6% | 226M+0.7% | N/A | 233M+14.2% | 229M+25.4% | 225M+23.7% | N/A | 204M+12.2% |
Not reported in any period shown, so not listed: EBITDA, Interest Expense.
AVPT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $757.0M+8.1% | $734.2M+22.6% | $789.2M+52.0% | $743.5M+60.6% | $700.1M+63.9% | $598.8M+44.7% | $519.1M+17.3% | $463.0M+16.3% |
| Current Assets | $557.5M+3.3% | $562.2M+25.9% | $625.3M+58.4% | $580.7M+70.3% | $539.8M+70.3% | $446.6M+47.1% | $394.8M+21.3% | $341.0M+18.9% |
| Cash & Equivalents | $417.3M-2.9% | $444.1M+26.4% | $481.1M+65.5% | $471.6M+88.8% | $429.8M+89.3% | $351.5M+63.1% | $290.7M+30.3% | $249.8M+21.4% |
| Short-Term Investments | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $325K-91.5% | $317K-91.6% | $167K-95.5% | $173K-95.0% |
| Accounts Receivable | $117.0M+25.4% | $100.4M+25.3% | $124.5M+42.5% | $90.9M+13.6% | $93.3M+19.0% | $80.1M+9.2% | $87.4M+1.7% | $80.0M+15.4% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $36.8M-5.3% | $37.2M+1.1% | $38.0M+114.4% | $37.9M+99.5% | $38.8M+110.1% | $36.8M+96.7% | $17.7M-7.5% | $19.0M+2.2% |
| Total Liabilities | $320.1M+24.6% | $295.4M+24.4% | $310.5M+25.1% | $276.7M+11.9% | $257.0M+16.9% | $237.4M+18.1% | $248.1M+13.9% | $247.2M+34.3% |
| Current Liabilities | $278.9M+22.2% | $260.3M+25.0% | $273.7M+22.8% | $244.9M+25.8% | $228.2M+32.1% | $208.2M+27.4% | $223.0M+26.2% | $194.7M+30.8% |
| Non-Current Liabilities | $41.2M+43.2% | $35.1M+20.3% | $36.8M+46.3% | $31.9M-39.4% | $28.8M-39.0% | $29.2M-22.4% | $25.2M-38.8% | $52.5M+48.9% |
| Total Equity | $436.9M-1.4% | $438.8M+22.1% | $478.7M+77.9% | $466.8M+118.3% | $443.1M+115.2% | $359.5M+69.0% | $269.2M+23.0% | $213.8M+6.8% |
| Retained Earnings | -$531.7Mn/m | -$531.3Mn/m | -$510.1Mn/m | -$510.9Mn/m | -$517.9Mn/m | -$515.5Mn/m | -$510.4Mn/m | -$484.5Mn/m |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
AVPT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.9M-21.4% | $24.3M+4801.0% | $29.7M-9.5% | $34.8M+8.1% | $20.3M+25.4% | $495K-93.6% | $32.8M+53.0% | $32.2M+699.9% |
| Stock-Based Compensation | N/A | $7.3M-24.4% | N/A | $10.7M+8.8% | $11.1M+5.7% | $9.6M+1.7% | N/A | $9.8M |
| Capital Expenditures | $1.2M+25.1% | $1.3M-15.7% | $697K-5.9% | $507K-64.0% | $965K+144.9% | $1.5M+201.6% | $741K+21.7% | $1.4M+104.2% |
| Free Cash Flow | $14.7M-23.7% | $23.0Mn/m | $29.0M-9.5% | $34.3M+11.4% | $19.3M+22.5% | -$1.0M-114.0% | $32.0M+53.9% | $30.8M+822.8% |
| Investing Cash Flow | -$1.8Mn/m | -$1.6Mn/m | $11.0Mn/m | -$13.0M-1167.7% | -$1.3Mn/m | -$16.9Mn/m | -$1.2Mn/m | $1.2Mn/m |
| Financing Cash Flow | -$40.8M-169.8% | -$58.9M-177.3% | -$31.5M-348.1% | $20.8Mn/m | $58.5Mn/m | $76.2Mn/m | $12.7Mn/m | -$12.4Mn/m |
| Share Buybacks | $50.5M+616.6% | $59.8M+402.4% | $22.4M+97.7% | $8.4M+227.3% | $7.0M+30.3% | $11.9M-13.4% | $11.3M+110.5% | $2.6M-84.7% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Dividends Paid.
AVPT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.1%-0.9pp | 72.8%-1.5pp | 73.6%-1.8pp | 74.4%-1.7pp | 74.0%-1.7pp | 74.3%+1.7pp | 75.4%+1.7pp | 76.1%+3.8pp |
| Operating Margin | 8.2%+1.3pp | 10.9%+7.3pp | 12.7%+7.2pp | 7.4%-1.2pp | 7.0%+9.7pp | 3.5%+7.8pp | 5.4%+4.3pp | 8.6%+9.0pp |
| Net Margin | 22.1%+19.5pp | 13.0%+9.3pp | 13.6%+32.9pp | 11.9%+8.9pp | 2.6%+19.1pp | 3.7%+6.0pp | -19.3%-25.0pp | 2.9%+8.7pp |
| Return on Equity | 6.3%+5.7pp | 3.5%+2.5pp | 3.3%+9.7pp | 2.8%+1.6pp | 0.6%+6.8pp | 1.0%+1.8pp | -6.4%-8.3pp | 1.2%+3.3pp |
| Return on Assets | 3.6%+3.3pp | 2.1%+1.5pp | 2.0%+5.3pp | 1.8%+1.2pp | 0.4%+3.4pp | 0.6%+1.0pp | -3.3%-4.3pp | 0.6%+1.6pp |
| Current Ratio | 2.00-0.4x | 2.160.0x | 2.28+0.5x | 2.37+0.6x | 2.37+0.5x | 2.15+0.3x | 1.77-0.1x | 1.75-0.2x |
| Liabilities-to-Equity | 0.73+0.2x | 0.670.0x | 0.65-0.3x | 0.59-0.6x | 0.58-0.5x | 0.66-0.3x | 0.92-0.1x | 1.16+0.2x |
| Asset Turnover | 0.160.0x | 0.160.0x | 0.150.0x | 0.150.0x | 0.150.0x | 0.160.0x | 0.170.0x | 0.190.0x |
| FCF Margin | 11.8%-7.1pp | 19.6%+20.7pp | 25.3%-10.6pp | 31.3%-3.4pp | 18.9%-1.3pp | -1.1%-10.8pp | 35.9%+8.0pp | 34.7%+30.1pp |
Not reported in any period shown, so not listed: Debt-to-Equity.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| AvePoint, Inc. AVPT | FY2025 | $419.5M | $34.8M | 8.3% | $3.6B | 61/100 |
| Tenable Holdings, Inc. TENB | FY2025 | $999.4M | -$36.1M | -3.6% | $5.3B | 42/100 |
| DigitalOcean Holdings, Inc. DOCN | FY2025 | $901.4M | $259.3M | 28.8% | $11.7B | 49/100 |
| Cellebrite DI Ltd. CLBT | FY2025 | $475.7M | $78.3M | 16.5% | $3.1B | 67/100 |
| Euronet Worldwide Inc EEFT | FY2025 | $4.2B | $309.5M | 7.3% | $2.4B | 66/100 |
| Remitly Global, Inc. RELY | FY2025 | $1.6B | $67.9M | 4.2% | $5.2B | 67/100 |
Where AvePoint, Inc. Ranks
Frequently Asked Questions
What is AvePoint, Inc.'s annual revenue?
AvePoint, Inc. (AVPT) reported $419.5M in total revenue for fiscal year 2025. This represents a 26.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is AvePoint, Inc.'s revenue growing?
AvePoint, Inc. (AVPT) revenue grew by 26.9% year-over-year, from $330.5M to $419.5M in fiscal year 2025.
Is AvePoint, Inc. profitable?
Yes, AvePoint, Inc. (AVPT) reported a net income of $71.5M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $34.8M, with a net profit margin of 8.3%.
What is AvePoint, Inc.'s EBITDA?
AvePoint, Inc. (AVPT) had EBITDA of $36.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is AvePoint, Inc.'s gross margin?
AvePoint, Inc. (AVPT) had a gross margin of 74.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is AvePoint, Inc.'s operating margin?
AvePoint, Inc. (AVPT) had an operating margin of 7.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is AvePoint, Inc.'s net profit margin?
AvePoint, Inc. (AVPT) had a net profit margin of 8.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is AvePoint, Inc.'s return on equity (ROE)?
AvePoint, Inc. (AVPT) has a return on equity of 7.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is AvePoint, Inc.'s free cash flow?
AvePoint, Inc. (AVPT) generated $81.6M in free cash flow during fiscal year 2025. This represents a -5.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is AvePoint, Inc.'s operating cash flow?
AvePoint, Inc. (AVPT) generated $85.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are AvePoint, Inc.'s total assets?
AvePoint, Inc. (AVPT) had $789.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are AvePoint, Inc.'s capital expenditures?
AvePoint, Inc. (AVPT) invested $3.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does AvePoint, Inc. spend on research and development?
AvePoint, Inc. (AVPT) invested $52.6M in research and development during fiscal year 2025.
What is AvePoint, Inc.'s current ratio?
AvePoint, Inc. (AVPT) had a current ratio of 2.28 as of fiscal year 2025, which is generally considered healthy.
What is AvePoint, Inc.'s liabilities-to-equity ratio?
AvePoint, Inc. (AVPT) had a liabilities-to-equity ratio of 0.65 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is AvePoint, Inc.'s return on assets (ROA)?
AvePoint, Inc. (AVPT) had a return on assets of 4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is AvePoint, Inc.'s P/E ratio?
AvePoint, Inc. (AVPT) trades at 49.9x earnings, its market capitalization divided by $71.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.6B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is AvePoint, Inc.'s price-to-sales ratio?
AvePoint, Inc. (AVPT) trades at 7.6x sales, its market capitalization divided by $466.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.6B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is AvePoint, Inc.'s Altman Z-Score?
AvePoint, Inc. (AVPT) has an Altman Z-Score of 7.19, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is AvePoint, Inc.'s Piotroski F-Score?
AvePoint, Inc. (AVPT) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are AvePoint, Inc.'s earnings high quality?
AvePoint, Inc. (AVPT) has an earnings quality ratio of 2.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is AvePoint, Inc.?
AvePoint, Inc. (AVPT) scores 61 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.